Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-151,584
-151,584
-236,568
-250,460
-276,852
Depreciation & amortisation
7,873
7,873
5,342
6,209
8,846
Deferred income taxes
-4,939
-4,939
9
34
-155
Stock-based compensation
86,077
86,077
76,512
57,838
49,151
Change in working capital
-26,643
-26,643
-39,880
-18,585
-32,064
Accounts receivable
-20,108
-20,108
-17,330
-8,189
-11,219
Inventory
-44,614
-44,614
-5,343
-7,790
-4,639
Accounts payable
49,195
49,195
-6,377
7,430
-10,610
Other working capital
-76,531
-76,531
-170,341
-206,375
-236,517
Other non-cash items
-16,148
-16,148
3,712
-1,349
4,938
Net cash provided by operating activities
-69,091
-69,091
-166,575
-202,491
-233,290
Cash flows from investing activities
Investments in property, plant and equipment
-7,440
-7,440
-3,766
-3,884
-3,227
Purchases of investments
-91,723
-91,723
-243,255
-341,398
-365,178
Sales/maturities of investments
197,227
197,227
335,926
424,043
354,826
Other investing activities
-
-
3,411
-
-
Net cash used for investing activities
98,064
98,064
92,316
78,761
-13,579
Cash flows from financing activities
Debt repayment
-408,318
-408,318
-283
-479
-155,325
Common stock issued
92,935
92,935
0
199,750
0
Other financing activities
19,875
-20,573
-11,490
-16,656
-10,028
Net cash used provided by (used for) financing activities
61,677
61,677
-7,463
212,073
262,858
Net change in cash
96,962
96,962
-96,341
83,294
19,819
Cash at beginning of period
153,115
153,115
249,456
166,162
146,343
Cash at end of period
250,077
250,077
153,115
249,456
166,162
Free cash flow
Operating cash flow
-69,091
-69,091
-166,575
-202,491
-233,290
Capital expenditure
-7,440
-7,440
-3,766
-3,884
-3,227
Free cash flow
-76,531
-76,531
-170,341
-206,375
-236,517
© 2024 Yahoo. All rights reserved.